Halozyme Therapeutics (HALO) Insider Trading & Ownership $45.76 +0.95 (+2.12%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Halozyme Therapeutics (NASDAQ:HALO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$9.06 M Get HALO Insider Trade Alerts Want to know when executives and insiders are buying or selling Halozyme Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address HALO Insider Buying and Selling by Quarter Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. Halozyme Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/16/2024Michael J LabarreSVPSell10,000$53.26$532,600.00 10/9/2024Helen TorleyCEOSell10,000$52.58$525,800.00 9/25/2024Helen TorleyCEOSell10,000$56.34$563,400.00 9/18/2024Michael J LabarreSVPSell10,000$62.03$620,300.00 9/12/2024Helen TorleyCEOSell10,000$59.20$592,000.00 9/10/2024Helen TorleyCEOSell10,000$59.09$590,900.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/9/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$59.24$1,001 - $15,0008/21/2024Michael J LabarreSVPSell10,000$61.75$617,500.00 8/14/2024Matthew L PosardDirectorSell9,881$57.70$570,133.70 8/12/2024Matthew L PosardDirectorSell10,000$55.72$557,200.00 7/24/2024Michael J LabarreSVPSell10,000$55.12$551,200.00 7/22/2024Nicole LabrosseCFOSell5,000$53.93$269,650.00 6/27/2024Nicole LabrosseCFOSell10,000$51.93$519,300.00 6/11/2024Matthew L PosardDirectorSell10,000$50.01$500,100.00 5/22/2024Michael J LabarreSVPSell10,000$45.38$453,800.00 4/17/2024Michael J LabarreSVPSell10,000$38.49$384,900.00 3/12/2024Michael J LabarreSVPSell10,000$41.64$416,400.00 2/28/2024Michael J LabarreSVPSell10,000$39.55$395,500.00 12/12/2023Michael J LabarreSVPSell10,000$39.63$396,300.00 (Data available from 1/1/2013 forward) HALO Insider Trading Activity - Frequently Asked Questions Who is on Halozyme Therapeutics's Insider Roster? The list of insiders at Halozyme Therapeutics includes Helen Torley, James M Daly, Jeffrey William Henderson, Matthew L Posard, Michael J Labarre, and Nicole Labrosse. Learn more on insiders at HALO. What percentage of Halozyme Therapeutics stock is owned by insiders? 2.70% of Halozyme Therapeutics stock is owned by insiders. Learn more on HALO's insider holdings. Which Halozyme Therapeutics insiders have been selling company stock? The following insiders have sold HALO shares in the last 24 months: Helen Torley ($7,021,264.86), James M Daly ($874,500.00), Jeffrey William Henderson ($477,100.00), Matthew L Posard ($2,772,833.70), Michael J Labarre ($9,167,900.00), and Nicole Labrosse ($913,331.50). How much insider selling is happening at Halozyme Therapeutics? Insiders have sold a total of 438,467 Halozyme Therapeutics shares in the last 24 months for a total of $21,226,930.06 sold. Which members of congress are trading Halozyme Therapeutics? Josh Gottheimer (D-NJ) has sold shares of Halozyme Therapeutics in the last year totaling $8,000. Halozyme Therapeutics Key ExecutivesDr. Helen I. Torley M.B. Ch. B. (Age 61)M.R.C.P., President, CEO & Director Compensation: $1.82MMs. Nicole LaBrosse (Age 41)Senior VP & CFO Compensation: $849.36k2 recent tradesDr. Michael J. LaBarre Ph.D. (Age 60)Senior VP & CTO Compensation: $843.89kMr. Mark Snyder Esq.Senior VP & Chief Legal OfficerMs. Cortney Caudill M.B.A.Chief Operations OfficerMs. Tram BuiHead of Investor Relations & Corporate CommunicationsMs. Amy Marinne FoxChief Human Resources OfficerMr. Gary GroteChief Commercial OfficerDr. Christopher Wahl M.B.A.M.D., Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies IOVA Insider Buying TWST Insider Buying RLAY Insider Buying ADPT Insider Buying ALLO Insider Buying KOD Insider Buying FATE Insider Buying BIIB Insider Buying UTHR Insider Buying INCY Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:HALO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Halozyme Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HALO Stock Alerts